Rene Reinbigler is a Director and Enterprise Architect in Software & Automation division of Merck Life Science. He has impressive 29 years experience in biopharma industry designing upstream and downstream equipment and supporting customers around the world in setting up, qualifying and troubleshooting production process of monoclonal antibodies. Rene is the co-author of 25+ patents in area of automation and bioprocessing. His passion for technology makes him a visionary leader. Rene's main areas of expertise are Automation, IoT, AR and digitalization in general. He is currently working on innovative IIoT solutions which have potential to revolutionize how the bioprocess is being executed.

EMD Millipore (doing business as MilliporeSigma) is about making life science research, development, and production faster, easier, and more effective. The company is a US-based subsidiary and one of four main divisions of Germany's Merck KGaA. Outside of North America, it is known as the Merck Millipore division. The company is a top-tier supplier of a comprehensive set of products and services primarily to pharma, biotech, and academic markets worldwide. Its product portfolio includes more than 60,000 active pharmaceutical ingredients, drug delivery compounds, chemicals and reagents, and instruments. With the parent company's 2015 acquisition of Sigma-Aldrich, EMD Millipore began operating as MilliporeSigma in the US and Canada.